Wouters J - Search Results

1

Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.

Michaux C, Norberg B, Dogné JM, Durant F, Masereel B, Delarge J, Wouters J. Michaux C, et al. Among authors: wouters j. Acta Crystallogr C. 2000 Oct;56 ( Pt 10):1265-6. doi: 10.1107/s0108270100009872. Acta Crystallogr C. 2000. PMID: 11025320

2

Secondary structure of monoamine oxidase by FTIR spectroscopy.

Wouters J, Ramsay R, Goormaghtigh E, Ruysschaert JM, Brasseur R, Durant F. Wouters J, et al. Biochem Biophys Res Commun. 1995 Mar 17;208(2):773-8. doi: 10.1006/bbrc.1995.1404. Biochem Biophys Res Commun. 1995. PMID: 7695635

3

Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme.

Wouters J, Moureau F, Vercauteren DP, Evrard G, Durant F, Koenig JJ, Ducrey F, Jarreau FX. Wouters J, et al. J Neural Transm Suppl. 1994;41:313-9. doi: 10.1007/978-3-7091-9324-2_41. J Neural Transm Suppl. 1994. PMID: 7931244

4

Kinetic characterization of tyramine oxidase of Arthrobacter species.

Wouters J, Perpète P, Hayen P, Anceau N, Durant F. Wouters J, et al. Biochem Mol Biol Int. 1994 Mar;32(4):737-43. Biochem Mol Biol Int. 1994. PMID: 8038724

5

Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.

Masereel B, Wouters J, Pochet L, Lambert D. Masereel B, et al. Among authors: wouters j. J Med Chem. 1998 Aug 13;41(17):3239-44. doi: 10.1021/jm981022n. J Med Chem. 1998. PMID: 9703469

6

Molecular lipophilicity potential by CLIP, a reliable tool for the description of the 3D distribution of lipophilicity: application to 3-phenyloxazolidin-2-one, a prototype series of reversible MAOA inhibitors.

Ooms F, Wouters J, Collin S, Durant F, Jegham S, George P. Ooms F, et al. Among authors: wouters j. Bioorg Med Chem Lett. 1998 Jun 2;8(11):1425-30. doi: 10.1016/s0960-894x(98)00230-3. Bioorg Med Chem Lett. 1998. PMID: 9871778

7

A reversible monoamine oxidase A inhibitor, befloxatone: structural approach of its mechanism of action.

Wouters J, Moureau F, Evrard G, Koenig JJ, Jegham S, George P, Durant F. Wouters J, et al. Bioorg Med Chem. 1999 Aug;7(8):1683-93. doi: 10.1016/s0968-0896(99)00102-9. Bioorg Med Chem. 1999. PMID: 10482460

8

Antagonism of the TXA2 receptor by seratrodast: a structural approach.

Wouters J, Durant F, Masereel B. Wouters J, et al. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2867-70. doi: 10.1016/s0960-894x(99)00490-4. Bioorg Med Chem Lett. 1999. PMID: 10522708

9

Structural analysis of pyrrolidinones.

Camus F, Norberg B, Legrand A, Rigo B, Durant F, Wouters J. Camus F, et al. Among authors: wouters j. Acta Crystallogr C. 2000 Feb;56 ( Pt 2):193-6. doi: 10.1107/s0108270199013037. Acta Crystallogr C. 2000. PMID: 10777884 No abstract available.

10

Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase.

Pochet L, Doucet C, Dive G, Wouters J, Masereel B, Reboud-Ravaux M, Pirotte B. Pochet L, et al. Among authors: wouters j. Bioorg Med Chem. 2000 Jun;8(6):1489-501. doi: 10.1016/s0968-0896(00)00071-7. Bioorg Med Chem. 2000. PMID: 10896125 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

752 results

Search Page

Filters